This year’s ESC Acute CardioVascular Care congress, organised by the Association on CardioVascular Care (ACVC) of the European Society of Cardiology (ESC), will take place in Florence, Italy, from March 14-15.  

ESC Acute CardioVascular Care  brings together expertise from emergency medicine, intensive care, anaesthesiology, radiology, nursing, medical technology, paramedics, and many other healthcare professions. It is a highly multidisciplinary field and often deals with patients in life-and-death situations. 

On Tuesday 25 February, a task force of more than 70 leaders from science, industry, academia, and philanthropy – chaired by AAAS CEO Sudip Parikh – unveiled the Vision for American Science and Technology (VAST), a bold, strategic vision to strengthen the U.S. science and technology enterprise and ensure the U.S. remains globally competitive. VAST identifies key avenues to reduce barriers that hinder progress, build and empower a stronger and more adaptable workforce, and advance our global competitiveness while addressing societal challenges with commitments to fundamental discovery research. The VAST Task Force’s recommendations will unlock the U.S. science and technology enterprise’s full potential and secure our economic prosperity for future generations. You can read more here: https://www.vastfuture.org/

Cambridge, MA, Mar 3, 2025 --- Insilico Medicine ("Insilico"), a clinical stage generative artificial intelligence (AI)-driven biotechnology company, and Tenacia Biotechnology (“Tenacia”), a commercial-stage biopharmaceutical company developing and commercializing innovative treatments for nervous system disorders, today announced a strategic research collaboration. Focused on certain potential targets, Insilico and Tenacia will collaborate during the early discovery stage of novel Central Nervous System (CNS) disease therapies, developing small molecule inhibitors from scratch to preclinical candidate nomination.